Indivior shares dive after Dr Reddy's gets FDA approval for generic

(Reuters) - Britain's Indivior fell by more than 20 percent on Friday after the U.S Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80 percent of its revenue.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news